Positive aspects of transcervical fibroid ablation, strong clinical results, provides facilities with confidence in treating fibroids and minimizing potential viral risks – procedural volumes increasing Redwood City, CA – June 22, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, [...]
MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European Spine Journal publication of long-term data from the Level I SMART trial showing durability of improvements in pain and function beyond 5 years [...]
The Sonata System provides advantages in reducing the index procedure cost, length of stay (LOS), prescription medications, complications and radiology costs versus hysterectomy and myomectomy Redwood City, CA – June 4, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine [...]
08 June, 2020 Bernard Vogel, Managing Partner at Endeavour Vision The medtech industry has never in history been of such pivotal importance as in the last few months during the pandemic. As countries all over the world grappled with the devastating impact of the virus, medtech suppliers of ventilators, [...]
Endeavour Vision was featured in Swiss newspaper Le Temps on 30 May, 2020. Read the original article or scroll down for the English translation. Actif dans les technologies médicales et la santé numérique, le fonds genevois Endeavour Vision voit son modèle d’affaires renforcé par la pandémie. Cofondateur de la [...]
Early launch in Europe contributes to significant procedural growth Redwood City, CA – May 28, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) [...]
Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support new product development for pandemic response. Global investor syndicate is led by Ally Bridge Group, joined by Endeavour Vision, and [...]
DARPin® antiviral candidates demonstrate low picomolar potency in live virus assay Candidate construction complete; two candidates ready for preclinical development & manufacturing Therapeutic profile of a highly potent antiviral biologic with a long half-life supports both a prophylactic and therapeutic approach Initiation of clinical studies planned for H2 2020 [...]
Endeavour Vision’s Co-Founder and Managing Partner, Bernard Vogel, spoke to the Swiss news publication, AGEFI, to share his insights on the impact of COVID-19 on Swiss start-ups, the medtech sector and the firm’s investment strategy. Scroll down for the English translation. Published in AGEFI on 20 April, 2020. Pour [...]
SOPHiA GENETICS Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer Lausanne, Switzerland, and Boston, United States, April 8, 2020 - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be [...]